Michael Cato
Corporate Officer/Principal bei Cato Research LLC
Profil
Michael Cato's current job is as Vice President-Quality Assurance at Cato Research LLC since 2005.
His former jobs include being an Associate at Cato BioVentures and serving as President at Hemodynamic Therapeutics, Inc. from 2000 to 2012.
He obtained a graduate degree from North Carolina State University.
Aktive Positionen von Michael Cato
Unternehmen | Position | Beginn |
---|---|---|
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01.06.2005 |
Ehemalige bekannte Positionen von Michael Cato
Unternehmen | Position | Ende |
---|---|---|
Hemodynamic Therapeutics, Inc.
Hemodynamic Therapeutics, Inc. BiotechnologyHealth Technology Hemodynamic Therapeutics, Inc. develops a novel small molecule combination therapy for obesity-related hypertension. The firm is developing its novel small molecule combination therapy (HTI-101) for obesity-related hypertension, one of the world's fastest growing cardiovascular disease markets. It has recently completed an initial Phase 2 clinical trial of HTI-101 in obese individuals with mild to moderate treatment-resistant hypertension. The company was founded in 2004 and is headquartered in Raleigh, NC. | Präsident | - |
Cato BioVentures
Cato BioVentures Investment ManagersFinance Cato BioVentures (Cato BioVentures) is a venture capital subsidiary of Cato Research LLC founded in 1990 by Allen Cato and Lynda Sutton. The firm is headquartered in Durham, North Carolina. | Private-Equity-Analyst | - |
Ausbildung von Michael Cato
North Carolina State University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Cato BioVentures
Cato BioVentures Investment ManagersFinance Cato BioVentures (Cato BioVentures) is a venture capital subsidiary of Cato Research LLC founded in 1990 by Allen Cato and Lynda Sutton. The firm is headquartered in Durham, North Carolina. | Finance |
Hemodynamic Therapeutics, Inc.
Hemodynamic Therapeutics, Inc. BiotechnologyHealth Technology Hemodynamic Therapeutics, Inc. develops a novel small molecule combination therapy for obesity-related hypertension. The firm is developing its novel small molecule combination therapy (HTI-101) for obesity-related hypertension, one of the world's fastest growing cardiovascular disease markets. It has recently completed an initial Phase 2 clinical trial of HTI-101 in obese individuals with mild to moderate treatment-resistant hypertension. The company was founded in 2004 and is headquartered in Raleigh, NC. | Health Technology |
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Commercial Services |